Skip to main content
ZVRA logo

ZVRA · Zevra Therapeutics, Inc. · Proposed Sales

Track ZVRA — free
$9.13 -0.16 (-1.67%) Play latest call Q3 2026 earnings call transcript
Market Cap
$552.20M
Shares
59.50M
Volume · Nov 19 123.69K Avg daily vol (3M) 954.6K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-13 NEIL F MCFARLANE 20,000
2026-08-14 RAHSAAN THOMPSON 42,666
2026-07-08 JOHN BODE 10,516
2026-05-11 Rahsaan Thompson 36,351
2026-03-16 RAYMOND L CLIFTON 345,428
2026-02-02 NEIL F MCFARLANE 105,625
2026-01-30 ADRIAN QUARTEL 4,533
2026-01-30 R LaDuane Clifton 14,000
2026-01-30 RAHSAAN THOMPSON 4,080
2026-01-30 TIMOTHY SANGIOVANNI 4,750
2026-01-30 JOSHUA SCHAFER 13,875
2025-10-10 NEIL F MCFARLANE 19,500
2025-06-26 RAHSAAN THOMPSON 24,000
2025-02-13 Timothy Sangiovanni 3,000
2025-02-13 Joshua Schafer 10,500
2025-02-13 R. LADUANE CLIFTON 11,000
2025-02-13 NEIL F MCFARLANE 91,817
Showing 1–17 of 17 filings
Key facts CIK 1434647 CUSIP 488445206 13F (30d) 188 filings 164 filers Visit website Investor relations